文献速递眼底病与葡萄膜炎

抗VEGF治疗后1型黄斑新生血管前表面血管特征分析

Characterisation of the vascular anterior surface of type 1 macular neovascularisation after anti-VEGF therapy.
PubMed 文献 · Br J Ophthalmol · 2022-05-10

研究评估1型黄斑新生血管(MNV)顶部血管状态是否介导对抗完全性视网膜色素上皮和外层视网膜萎缩(cRORA)的保护效应。44眼接受抗VEGF治疗,20眼进展为cRORA,基线及末次随访时neo-CC面积与MNV面积比值较低与cRORA发生风险增加相关。

要点

  • 44眼中20眼最终进展为cRORA,24眼未进展至萎缩。
  • 进展cRORA眼的前表面neo-CC比例显著低于未进展眼。
  • 多变量回归显示neo-CC覆盖MNV比例较低与cRORA发生风险增加相关。

核心结论

  • 更广泛的neo-CC覆盖与接受抗VEGF治疗眼发生黄斑萎缩的可能性较低相关,提示1型MNV的保护效应可能由neo-CC的形成所介导。

研究设计与样本

  • 连续纳入的未治疗患者中,利用定制slab分离MNV前表面血管(neo-CC),评估基线及末次随访时neo-CC面积与MNV面积的比值。

主要发现

  • 44例患者44眼纳入,20眼最终随访(中位23个月)时出现cRORA,24眼未进展至萎缩(中位23.5个月)。
  • 进展为cRORA眼的前表面存在neo-CC的MNV比例显著低于未进展眼。
  • 多变量回归显示,neo-CC覆盖MNV比例较低与cRORA发生风险增加相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate whether the status of vasculature at the top of type 1 macular neovascularisation (MNV) could function as mediator of the observed protective effect against the development of complete retinal pigment epithelial and outer retinal atrophy (cRORA). METHODS: In consecutive treatment-naïve patients, the vasculature at the anterior surface of the MNV was isolated using a slab designed to extract the most superficial vascular portion of the MNV lesion showing a choriocapillaris (CC)-like structure which we termed the 'neo-CC'. The ratio between the neo-CC area (isolated using this custom slab) and the MNV area (isolated using the standard outer retina-CC slab) at baseline and at last follow-up was evaluated. RESULTS: Forty-four eyes from 44 patients were included. 20 showed cRORA by the final follow-up (median 23 months), whereas 24 did not progress to atrophy (median 23.5 months). The proportion of MNV with neo-CC at the anterior surface was significantly lower in eyes which progressed to cRORA compared with those which did not. The multivariate regression showed that a lower proportion of neo-CC coverage over the MNV was associated with an increased odds for cRORA development. CONCLUSIONS: More extensive coverage of neo-CC is associated with a lower likelihood of development of macular atrophy in eyes receiving antivascular endothelial growth factor therapy, suggesting the protective effect of a type 1 MNV may be mediated by the development of a neo-CC and may provide insights into the biological significance of MNV as a response mechanism in eyes with age-related macular degeneration.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Corvi F, Bacci T, Corradetti G, et al. Characterisation of the vascular anterior surface of type 1 macular neovascularisation after anti-VEGF therapy. Br J Ophthalmol. 2022. PMID: 35537801. doi:10.1136/bjophthalmol-2021-320047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。